Pacific Biosciences of California, Inc. (PACB): Price and Financial Metrics

Pacific Biosciences of California, Inc. (PACB)

Today's Latest Price: $3.38 USD

0.35 (-9.38%)

Updated Feb 26 4:00pm

Add PACB to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

PACB Stock Summary

  • PACB's price/sales ratio is 9.15; that's higher than the P/S ratio of 86.91% of US stocks.
  • With a year-over-year growth in debt of 332.69%, Pacific Biosciences Of California Inc's debt growth rate surpasses 94.21% of about US stocks.
  • Over the past twelve months, PACB has reported earnings growth of 24.61%, putting it ahead of 72.54% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Pacific Biosciences Of California Inc, a group of peers worth examining would be ONVO, NSTG, MRAM, PLUG, and VUZI.
  • Visit PACB's SEC page to see the company's official filings. To visit the company's web site, go to
PACB Daily Price Range
PACB 52-Week Price Range

PACB Stock Price Chart More Charts

PACB Price/Volume Stats

Current price $3.38 52-week high $7.50
Prev. close $3.73 52-week low $3.37
Day low $3.37 Volume 3,423,420
Day high $3.83 Avg. volume 2,895,098
50-day MA $4.82 Dividend yield N/A
200-day MA $5.44 Market Cap 517.02M

Pacific Biosciences of California, Inc. (PACB) Company Bio

Pacific Biosciences of California, Inc. designs, develops, manufactures, and markets an integrated platform for genetic analysis. The company was formerly known as Nanofluidics, Inc. The company was founded in 2000 and is based in Menlo Park, California.

PACB Latest News Stream

Event/Time News Detail
Loading, please wait...

PACB Latest Social Stream

Loading social stream, please wait...

View Full PACB Social Stream

PACB Price Returns

1-mo -30.88%
3-mo -33.86%
6-mo -39.10%
1-year -54.08%
3-year -33.98%
5-year -46.35%
YTD -34.24%
2019 -30.54%
2018 180.30%
2017 -30.53%
2016 -71.06%
2015 67.47%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6174 seconds.